{"id":9251,"date":"2023-09-06T00:12:01","date_gmt":"2023-09-06T04:12:01","guid":{"rendered":"https:\/\/www.med.unc.edu\/neurosurgery\/?post_type=directory&p=9251"},"modified":"2025-01-14T14:42:39","modified_gmt":"2025-01-14T19:42:39","slug":"daniel-pomeranz-krummel-phd","status":"publish","type":"directory","link":"https:\/\/www.med.unc.edu\/neurosurgery\/directory\/daniel-pomeranz-krummel-phd\/","title":{"rendered":"Daniel Pomeranz Krummel, PhD"},"content":{"rendered":"
Dr. Daniel Pomeranz Krummel\u2019s research focus is on the development of approaches to improve treatment of malignant brain tumors, both primary and metastatic. In collaboration with physician-scientist Dr. Soma Sengupta<\/a>, Dr. Pomeranz Krummel is advancing a novel class of small molecule compounds to improve effectiveness and reduce toxic side-effects of radiation, chemotherapy, and immunotherapy.<\/p>\n Dr. Pomeranz Krummel completed a PhD in biochemistry at Yale University, where he studied the structure-function of an RNA enzyme alongside his mentor, Dr. Sidney Altman, a recipient of the Nobel Prize for Chemistry (1989). It was at Yale that Dr. Pomeranz Krummel first crossed paths with his long-time collaborator, Dr. Soma Sengupta.<\/p>\n After doctoral research, he went to work at the Laboratory of Molecular Biology in Cambridge, U.K. There he obtained the first structural insight into an integral part of a very large complex called the spliceosome, a landmark achievement at the time. The spliceosome is responsible for the maturation of protein-coding gene mRNA transcripts.<\/p>\n Dr. Pomeranz Krummel transitioned his research focus to drug development for treatment of adult and pediatric patients diagnosed with primary brain tumors. More recently, he has also pursued developing treatments for metastatic brain cancers, specifically in lung cancer.<\/p>\n Dr. Pomeranz Krummel currently works collaboratively with Dr. Sengupta in a shared lab on ºÚÁÏÍø\u2019s campus.<\/p>\n<\/div>\n Research Associate Professor<\/p>\n Malignant brain tumors<\/p>\n SoDa Lab<\/a><\/p>\n Postdoctoral Fellowship in Structural Studies \u2013 Cambridge, U.K., 2008 Associate Professor (Research), University of Cincinnati College of Medicine, Cincinnati, OH, 2019-2023 For recent publications, visit Dr. Daniel Pomeranz Krummel’s PubMed listing<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Dr. Daniel Pomeranz Krummel\u2019s research focus is on the development of approaches to improve treatment of malignant brain tumors, both primary and metastatic. In collaboration with physician-scientist Dr. Soma Sengupta, Dr. Pomeranz Krummel is advancing a novel class of small molecule compounds to improve effectiveness and reduce toxic side-effects of radiation, chemotherapy, and immunotherapy. Dr. … Read more<\/a><\/p>\n","protected":false},"featured_media":10585,"template":"","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","_links_to":"","_links_to_target":""},"class_list":["post-9251","directory","type-directory","status-publish","has-post-thumbnail","hentry","odd"],"acf":[],"yoast_head":"\nTitle<\/h3>\n
Research Interests<\/h3>\n
Research Lab<\/h3>\n
Education and Training<\/h3>\n
\nPh.D. in Biochemistry \u2013 Yale University, 2000
\nB.S in Chemistry \u2013 State University of New York, 1994<\/p>\nOther Experience & Professional Membership<\/h3>\n
\nMember, Brain Tumor Center, University of Cincinnati Gardner Neuroscience Institute, 2019-2023
\nPresident, CEO, Co-Founder of Amlal Pharmaceuticals Inc.
\nAssistant Professor (Research), Department of Neurology\/Division of Neuro-Oncology, Emory School of Medicine, Atlanta, GA, 2016-2019
\nMember, Discovery & Developmental Therapeutics Program, Winship Cancer Institute, 2016-2019
\nAssistant Professor (Visiting), Department of Biochemistry, Brandeis University, Waltham, MA, 2016-2017
\nAssistant Professor, Department of Biochemistry, Brandeis University, Waltham, MA, 2009-2016
\nInvestigator Scientist, Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, U.K., 2008<\/p>\nRecent Publications<\/h3>\n